100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Notes lectures pulmonology theme minor clinical immunology $3.25   Add to cart

Class notes

Notes lectures pulmonology theme minor clinical immunology

 4 views  0 purchase
  • Course
  • Institution

Notes of all lectures giving during the pulmonology theme during the minor clinical immunology at the LUMC. Lectures which were given are: "Cell biology, immunology and host defense of the lungs"; "Lung cancer and immunotherapy"; "Immunology of lung diseases"; "Diagnostics in allergy and pulmonary ...

[Show more]

Preview 2 out of 10  pages

  • October 17, 2021
  • 10
  • 2021/2022
  • Class notes
  • A van der does, ps hiemstra, p. padmini s.j. khedoe, p. padmini s.j. khedoe, b stoel, m heuvers
  • All classes
avatar-seller
LT Cell biology, immunology and host defense of the
lungs
Epithelial cells are the first target in the lung of inhaled substances
Trachea/bronchus  bronchi  non-respiratory bronchioles  respiratory bronchioles 
alveolar ducts  alveoli (+ capillaries)
Epithelium consists of club cells, ciliated cells, goblet cells (mucus production) and basal cells
(progenitor cells)
Closer to the alveoli, there’re less goblet and basal cells
The alveoli (in the parenchyma) can be divided in alveolar type 1 and 2 cells; type 1 cells are
very thin, and diffusion takes place here; type 2 cells are the progenitor cells, and they
produce surfactant

The immune defense consists of resident cells and cells that are recruited during an infection
Several layers of respiratory host defense:
- Mechanical barrier (epithelium); adherens junctions and tight junctions keep a closed
barrier between the epithelial cells
- Ciliary action and mucus production (= mucociliary clearance); when it’s not working,
you cough to help to get rid of the stuff; the ciliary move at a certain frequency
- Production of cytokines and chemokines when the epithelium is triggered; released
into the lumen and blood
- Transport antibodies (IgE) from inside (blood) to outside (lumen of lungs); leads to
opsonization and neutralization (so the bacteria don’t reach the epithelium); done by
the receptor pIgR
- Production of endogenous antibiotics (body’s own antimicrobial peptides and
proteins); expressed by a variety of cells including epithelia and immune cells;
expression is constitutively or induced; antibacterial, antifungal, antiviral and
antiparasitic; depending on their levels, they’re pro-inflammatory or anti-
inflammatory, the same for anticancer activity; the antibiotics can modulate the
activity of immune cells, recruit immune cells or directly kill pathogen (lysis or
internal targets)
There’s also microbiota that live in the lung (like in the GI tract); but it is still unknown
whether it has a purpose or whether it just happens because you breathe in the air
containing bacteria
There’s a difference in the distribution of the microbiota throughout the lung due to
differences in pH, pO2, pCO2, temperature, etc.

COPD is a lung disease characterized by chronic inflammation, leading to tissue destruction
and a progressive decline in lung function
Main risks are cigarette smoking and air pollution
There’s more mucus production, but less ciliary activity, leading to much coughing; besides,
the diffusion surface is decreased; there’s remodeling of the lung epithelium (mucous
metaplasia and less ciliary cells)
The patients are vulnerable for infectious diseases (causing more damage)

Basal cells can differentiate in vitro creating a differentiated epithelium in vitro; this can be
used for research

, The electrical resistance is a measure for epithelial barrier function
Another way to measure the epithelial function is analyzing the microbial expression or
analyzing the transport of antibodies through the epithelium (pIgR activity)

LT Lung cancer and immunotherapy
Lung cancer is divided into non-small cell lung cancer (NSCLC) and small cell lung cancer
(SCLC); NSCLC is divided into adenocarcinoma, squamous cell carcinoma and large cell
carcinoma
SCLC is more aggressive than NSCLC; treated with radiation therapy and chemotherapy
50% of the NSCLC patients present with uncurable metastatic disease; treatment includes
surgery, chemotherapy, radiotherapy, targeted therapy (targeted at the mutation) and
immunotherapy

Intrinsic tumor suppression  senescence and apoptosis act as barrier against further
development of any neoplastic cell
Extrinsic tumor suppressor mechanisms provide further protection  dependence on
appropriate signals from micro-environment, prevention of cell cycle progression in face of
dysregulated junctional processes (cell polarity), limitation of transformation to tumor cell

The immune system protects the lungs from cancer by:
- Protecting the host form virus-induced tumors by eliminating viral infections
- Clearing inflammation (which is an environment that promotes tumorigenesis)
- Cancer immunosurveillance (elimination of tumor cells on basis of expression of
tumor-specific antigens)
The immune reaction can be in 3 phases  elimination of the tumor, equilibrium (stable
situation, tumor is controlled) or escape of the immune system by the tumor
When the antigens are lost, the equilibrium phase shifts to the escape phase
The immune reaction involves release of cancer antigens, presentation of these antigens by
APCs and dendritic cells, activation of T cells, trafficking of T cells, infiltration of T cells into
the tumor, recognition of the tumor by T cells and killing of the cancer cells

Mechanisms of escape (immunoediting):
- Reduced immune recognition by loss of HLA class I molecules  less recognition by
CD8 cytotoxic cells (but more recognition by NK cells)
- Increase resistance to attack by immune cells by increased expression of STAT3
(promotes proliferation and anti-apoptotic) and BCL-2 (anti-apoptotic)
- Development of immunosuppressive microenvironment by expression of cytokines
(VEGF, IL-10, TGF-b) and immunoregulatory molecules (checkpoint molecules) and by
infiltration of regulatory T cells and myeloid derived suppressor cells
Checkpoint molecules are e.g., PD-L1, CTLA4, TIGIT; high expression of these molecules
prevents apoptosis; these molecules can be used for targeted therapy  antibodies that
block the function of these molecules; for example, nivolumab which is IgG4 directed against
PD-1

Radiotherapy has the potential to induce stress responses and cell death in cancer cells and
thus drives dendritic cell-T cell interaction, but may also drive recruitment of innate immune
cells with tumor promoting potential

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller verabw. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $3.25. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75632 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$3.25
  • (0)
  Add to cart